Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease

Circulation

Volumn 100, Issue 19, 1999, Pages 1945-1950

  Fleisch, Martin ^a   Billinger, Michael ^a   Eberli, Franz R ^a   Garachemani, Ali R ^a   Meier, Bernhard ^a   Seiler, Christian ^a,b  

^a PSI   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Collateral circulation; Coronary disease; Growth substances

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH PROMOTOR; VASCULOTROPIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION FUNCTION; FEMALE; HEART CATHETERIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

EID: 0033539531     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.19.1945     Document Type: Article

References (27)

1. Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation. 1992;85:1197-1204.
2. Schaper W, Ito W. Molecular mechanisms of coronary collateral vessel growth. Circ Res. 1996;79:911-919.
3. D'Amore P, Thompson R. Mechanisms of angiogenesis. Annu Rev Physiol. 1987;49:453-464.
4. Kumar S, Shahabuddin S, Haboubi N, West D, Arnold F, Reid H, Carr T. Angiogenesis factor from human myocardial infarcts. Lancet. 1983;2: 364-368.
5. Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J, Epstein SE. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest. 1990;85:433-441.
6. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T, Tamaki S, Yamazato A, Sasayama S. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation. 1996;94:610-613.
7. Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary disease. Circulation. 1998;97:645-650.
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
9. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrera N, Symes JF, Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92(suppl II):II-365-II-371.
10. Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou AN, Stiber JA, Lobo AD, Hunsberger S, Guetta E, Epstein SE, Unger EF. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 1996;94:1074-1082.
11. Rentrop KP, Thornton JC, Feit F, Van Buskirk M. Determinants and protective potential of coronary arterial collaterals as assessed by an angioplasty model. Am J Cardiol. 1988;61:677-684.
12. Seiler C, Fleisch M, Garachemani AR, Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol. 1998;32:1272-1279.
13. Pijls NHJ, van Son JAM, Kirkeeide RL, de Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354-1367.
14. Menzel T, Rahmann Z, Calleja E, White K, Wilson EL, Wieder R, Gabrilove J. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood. 1996;87:1056-1063.
15. Arras M, Wulf DI, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40-50.
16. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
17. Yanagisawa-Miwa A; Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992;257:1401-1403.
18. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam MAS, Hunsberger S, Robison WG Jr, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995; 91:145-153.
19. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:35-34.
20. Hatt PY, Ledoux C, Bovalet JP, Guillemot H. Lyse et synthese des proteines myocardique au cours de l'insuffisance cardiaque experimentale. Arch Mal Coeur Vaiss. 1965;58:1703-1721.
21. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A. 1987;84:2292-2296.
22. Mormede P, Baird A, Pigeon P. Immunoreactive fibroblast growth factor (FGF) in rat tissues: molecular weight forms and the effects of hypophysectomy. Biochem Biophys Res Commun. 1985;128:1108-1113.
23. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JI. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-1123.
24. Sellke FW, Wang SY, Stamler A, Lopez JJ, Li J, Li J, Simons M. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol. 1996;271:H713-H720.
25. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837.
26. O'Brien ER, Garvin MR, Dev R. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994;145:883-894.
27. Medalion B, Merin G, Aingorn H, Miao H-Q, Nagler A, Elami A, Ishai-Michaeli R, Vlodavsky I. Endogenous basic fibroblast growth factor displaced by heparin from the lumenal surface of human blood vessels is preferentially sequestered by injured regions of the vessel wall. Circulation. 1997;95:1853-1862.